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Abstract
Anastomotic dehiscence is the most severe complication of colorectal surgery. Metalloproteinases (MMPs) and interleukins
(ILs) can be used to analyze the healing process of anastomosis. To evaluate the effects of bromopride on MMP and cytokine
gene expression in left colonic anastomoses in rats with or without induced abdominal sepsis, 80 rats were divided into two
groups for euthanasia on the third or seventh postoperative day (POD). They were then divided into subgroups of 20 rats for
sepsis induction or not, and then into subgroups of 10 rats for administration of bromopride or saline. Left colonic anastomosis
was performed and abdominal sepsis was induced by cecal ligation and puncture. A colonic segment containing the
anastomosis was removed for analysis of gene expression of MMP-1a, MMP-8, MMP-13, IL-b, IL-6, IL-10, tumor necrosis
factor-a (TNF-a), and interferon-c (IFN-c). On the third POD, bromopride was associated with increased MMP-1a, MMP-13, IL-
6, IFN-c, and IL-10 gene expression. On the seventh POD, all MMP transcripts became negatively modulated and all IL
transcripts became positively modulated. In the presence of sepsis, bromopride administration increased MMP-8 and IFN-c
gene expression and decreased MMP-1, TNF-a, IL-6, and IL-10 gene expression on the third POD. On the seventh POD, we
observed increased expression of MMP-13 and all cytokines, except for TNF-a. In conclusion, bromopride interferes with MMP
and IL gene expression during anastomotic healing. Further studies are needed to correlate these changes with the healing
process.
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Introduction
Anastomotic dehiscence is the most feared complica-
tion of colorectal surgery and may affect 2.4% to 3.8% of
patients undergoing this procedure (1,2). Several experi-
mental studies have been conducted to assess colonic
anastomotic healing as well as factors contributing to
anastomotic failure, such as fecal contamination and drug
administration (3,4).
Prokinetic agents are often used in the early post-
operative period to assist in gastric emptying and to ac-
celerate the resolution of paralytic ileus, especially after
intestinal surgery (5,6). The prokinetic drug class includes
substituted benzamides, such as metoclopramide (meth-
oxy-2-chloro-5-procainamide) and bromopride (4-amino-5-
bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide),
which act as dopamine antagonists. These drugs have both
antiemetic and motility-stimulating effects (7). Bromopride is
considered a good alternative to metoclopramide and other
antidopaminergic drugs, with fewer reports of extrapyrami-
dal side effects.
There is no consensus in the literature about the
mechanism of action of prokinetic agents on anastomotic
healing. Garcı´a-Olmo et al. (8) investigated the effects of
pharmacological manipulation of postoperative intestinal
motility on the resistance of colonic anastomoses and
concluded that the use of metoclopramide was associated
with fewer adhesions to the anastomosis and, conse-
quently, with a significant decrease in anastomotic resis-
tance 4 days after surgery.
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Conversely, in previous studies we found that admin-
istration of bromopride in the presence or absence of
sepsis was associated with decreased tensile strength of
left colonic anastomoses in rats 3 days after surgery, with
no changes in adhesion formation (9,10), suggesting that
other mechanisms may be involved. Therefore, the study
of other healing parameters to elucidate the real action of
bromopride on the healing process is needed.
Wound repair activates multiple biological pathways
that can restore tissue integrity in a sequence of events
and consists of three overlapping phases: inflammation,
formation of new tissues, and remodeling (11).
In the inflammatory phase that dominates the healing
process within the first days after wounding, leukocytes
produce large amounts of cytokines that interact to deter-
mine the vigor of the inflammatory response (12). These
interactions are complex and produce both pro- and anti-
inflammatory cytokines. The former include tumor necrosis
factor-a (TNF-a), interleukin (IL)-1b, IL-6, and IL-8, while the
latter include IL-4 and IL-10. The imbalance of cytokine
action during healing could explain anastomotic failure.
Collagen deposition is a further key mechanism of
wound healing (13). It is the most essential basal, skeletal
protein involved in the healing process (11). Metallo-
proteinases (MMPs) are a family of endopeptidases
involved in the degradation of extracellular matrix compo-
nents (14), coagulation, immunity, inflammation, angio-
genesis, tissue removal, connective tissue remodeling,
and epithelial cell and fibroblast migration (15,16). MMP-
1, MMP-8, and MMP-13 are collagenases that cleave
types I and III collagen fibers (14). An increased presence
of active forms of MMPs may lead to localized matrix
degradation and a transient loss of anastomotic strength,
thus leading to anastomotic dehiscence (17).
This study aimed to investigate whether the effect of
bromopride on anastomotic healing could be explained by
changes inMMP or cytokine gene expression caused by the
drug.
Material and Methods
The study was approved by the Animal Ethics
Committee of the Instituto de Cieˆncias Biologicas,
Universidade de Brası´lia, (UnBDOC protocol No. 67336/
2009), Brazil. All procedures were conducted in accordance
with the BrazilianGuidelines for Use of Animals inResearch.
Animals
Eighty healthy male Wistar rats (Rattus norvegicus)
were used in the study. The animals were 90 to 120 days
of age at the beginning of the experiment. For 2 weeks
preoperatively, the animals were housed in cages with 5
animals each, kept under a standard 12:12-h artificial
light-dark cycle, and had free access to water and
standard chow. There was no preoperative fasting period.
Experimental protocol
The rats were randomly divided into two groups of 40
animals each for euthanasia on the third or seventh
postoperative day (POD). Further randomization was
performed, and the animals were divided into subgroups
of 20 rats each for sepsis induction or not, and then into
subgroups of 10 rats each for administration of bromo-
pride or saline (Figure 1).
Figure 1. Allocation of animals to groups and
subgroups.
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General anesthesia was performed with 10 mg/kg
xylazine hydrochloride and 75 mg/kg ketamine hydro-
chloride administered intramuscularly. All surgical proce-
dures were performed by the same surgeon.
The surgical site was shaved and disinfected with
povidone-iodine. Clean, nonsterile surgical instruments
were used. A 4.0-cmmidline laparotomy incision was made,
starting 1.0 cm above the external genitalia. The distal colon
was exposed, and a 0.5-cm segment of the left colon (2.5
to 3.0 cm above the peritoneal reflection) was resected,
followed by end-to-end anastomosis of the resulting
segment, in a single transmural plane, using a continuous
6-0 polypropylene suture and a cylindrical needle.
After anastomosis, abdominal sepsis was experimen-
tally induced in all rats in the sepsis group using the cecal
ligation and puncture (CLP) method, as described by
Rittirsch et al. (18), where one-half of the cecum was
ligated using 3-0 silk suture (Shalon, Brazil). The end of the
cecum, located distal to the ligation, was punctured at 10
random sites using an 18G61.50 (40612 mm) venipunc-
ture needle, and some fecal content was extruded. The
abdominal wall was closed in two planes with a simple
running suture (3-0 silk suture).
Animals that died within the first 24 postoperative
hours were excluded from the study. Metamizole sodium
monohydrate (20 mg/kg) was added to the animals’ water
for analgesia until the day of euthanasia. No antibiotics
were used.
After the operations, animals in the experimental
subgroups received bromopride at a dose of 1 mg/100 g
subcutaneously every 12 h until the day of euthanasia.
Control animals received identical amounts of saline
subcutaneously every 12 h.
Reoperation was performed on the scheduled day for
each subgroup. After exposure of the abdominal cavity,
signs of anastomotic dehiscence were evaluated. A 4.0-
cm colonic segment, with the anastomosis at the center,
was removed as a whole together with any adherent
structures. For euthanasia, the rats received an overdose
of 150 mg/kg sodium thiopental injected directly into the
inferior vena cava.
Specimen preparation
After resection of the adherent structures, specimens
were opened at the antimesenteric border and divided into
longitudinal sections for later analysis of gene expression
of MMP-1a, MMP-8, MMP-13, IL-1b, IL-6, IL-10, TNF-a,
and interferon-c (IFN-c).
The anastomotic segment was macerated in TRI
Reagent solution (Applied Biosystems, USA), and RNA
was isolated by a single extraction with a phenol-chloroform
mixture and treated with Promega DNAse in the presence
of an RNAse inhibitor (Promega, catalog #M6101; Lot#
262753; USA) in order to remove all traces of residual
genomic DNA contamination, according to the protocol.
Equal amounts of 0.4 mg RNA were subjected to reverse
transcription with High Capacity cDNA Reverse Transcri-
ption kits (Applied Biosystems).
Real-time quantitative reverse transcription polymer-
ase chain reaction (PCR) was performed using a 7500 Fast
Real-Time PCR System (Applied Biosystems).
Amplification of cDNA sequences was performed using
the PCR Master Mix kit (Applied Biosystems) containing
the SYBR Green intercalating agent, a fluorescent mole-
cule that intercalates into double-stranded DNA after initial
denaturation at 956C for 15 s, followed by 606C for 1 min.
To confirm amplification specificity, PCR products were
analyzed by denaturation curves or melting curves.
Comparisons were made using the threshold cycle or
crossing point (19) method with cyclophilin to normalize
values in order to assess the variation in fold-change
expression of each gene. The fold-change expression
represents the ratio of the measured value for the treated
animals to the value for the nontreated cohorts. Values
greater than 2.0 were considered positively modulated,
whereas values less than 0.5 were negatively modulated.
We considered that there was no change in gene
expression in the range between these values. Reactions
were performed in triplicate for all genes analyzed. All
oligonucleotide pairs were designed using the Primer
Express software (Applied Biosystems; listed in Table 1).
Results
Effects of bromopride on nonseptic (NS) rats
There were no deaths in either group on the third or
seventh POD. One animal in the NS3 group and one in
the NS7 group had anastomotic leakage blocked by
adjacent organs, which was noticed only after opening the
surgical specimen. No animals in the control group had
anastomotic leakage.
Administration of bromopride was associated with
increased expression of MMP-1a and MMP-13 on the third
POD. On the seventh POD, transcripts of all MMPs of all
treated animals became negatively modulated (Table 2).
Administration of bromopride positively modulated IL-
6, IFN-c, and IL-10 gene expression on the third POD and
gene expression of all ILs on the seventh POD, especially
IL-1b (Table 2).
Effects of bromopride on septic rats
There were no deaths among animals euthanized on the
third POD. There was one death in each subgroup of animals
scheduled to be euthanized on the seventh POD, none of
them because of complications related to anastomosis.
On the third POD, one anastomotic dehiscence
blocked by omentum and adjacent organs occurred in
the bromopride-treated subgroup, and one free dehis-
cence, with the presence of feces in the abdominal cavity,
occurred in the control subgroup. On the seventh POD,
each subgroup showed one case of blocked anastomotic
dehiscence.
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On the third POD, administration of bromopride was
associated with increased MMP-8 gene expression and
decreasedMMP-13 gene expression. On the seventh POD,
only MMP-13 gene expression was increased (Table 2).
On the third POD, administration of bromopride was
associated with increased IFN-c gene expression and
decreased TNF-a, IL-6, and IL-10 gene expression. On
the seventh POD, gene expression of all cytokines was
positively modulated, except for TNF-a (Table 2).
Discussion
Bromopride is a prokinetic agent that is often used in
the postoperative period, but its effect on the healing
process has not been completely elucidated.
In the present study, administration of bromopride
increased expression of MMP-1a and MMP-13 in the
absence of abdominal sepsis and ofMMP-8 in the presence
of abdominal sepsis on the third POD. During the same
period, MMP-13 gene expression decreased under septic
conditions. On the seventh POD, transcripts of all MMPs of
bromopride-treated animals became negatively modulated
in the absence of abdominal sepsis, while MMP-13 gene
expression increased in the presence of sepsis.
Increased rates of anastomotic dehiscence have been
reported in patients with increased MMP-1, MMP-2, and
MMP-9 levels in perioperative colonic biopsies (20). Stumpf
et al. (21) demonstrated increased MMP-13 levels in
intestinal samples of patients with anastomotic dehiscence
compared to patients who did not have this complication,
with no differences in MMP-1 levels between groups. Pas-
ternak et al. (22) measured MMP-1, MMP-2, MMP-3, MMP-
7, MMP-8, MMP-9, and MMP-13 gene expression in the
postoperative intraperitoneal fluid of patients after anterior
resection of the rectum for cancer and found increased
MMP-8 and MMP-9 levels in patients who developed
Table 2. Fold-change expression of metalloproteinases and interleukins assessed in septic and non-septic rats.
Gene NS3 NS7 SS3 SS7
Metalloproteinases
MMP-1a 23.3271 ± 18.4817 0.4646 ± 0.2101 1.0673 ± 0.1777 1.0997 ± 0.7884
MMP-8 1.6812 ± 0.6944 0.0354 ± 0.0168 5.2162 ± 3.8970 1.5393 ± 1.3025
MMP-13 17.2923 ± 9.9203 0.2050 ± 0.0518 0.3280 ± 0.1026 20.4031 ± 20.2975
Interleukins
TNF-a 0.1485 ± 0.0853 7.0863 ± 1.3366 0.0356 ± 0.0148 1.6896 ± 0.6644
IL-6 7.0584 ± 5.6679 9.8259 ± 0.9167 0.0305 ± 0.0159 3.1797 ± 0.6608
IL-1b 0.2384 ± 0.0859 755.1999 ± 382.6502 2.0979 ± 2.1899 5.4248 ± 3.3516
IFN-c 1930.456 ± 1525.412 2.1702 ± 1.5530 27.8618 ± 8.6335 0.0009 ± 0.0005
IL-10 31599.72 ± 21986.74 29.7976 ± 26.0872 4.0860 ± 3.2465 15.9632 ± 2.1477
The fold-change expression represents the ratio of the measured value for the treated animals to the value for the nontreated cohorts.
Values greater than 2.0 were considered positively modulated, whereas values less than 0.5 were negatively modulated. MMP: matrix
metalloproteinase; TNF-a: tumor necrosis factor-a; IFN-c: interferon-c; IL: interleukin; NS3, NS7: non-septic rats receiving bromopride
euthanized on the 3rd and 7th postoperative day, respectively; SS3, SS7: septic rats receiving bromopride euthanized on the 3rd and
7th postoperative day, respectively.
Table 1. Genes and oligonucleotides used in real-time quantita-
tive reverse transcription polymerase chain reaction (qRT-PCR).
Genes Oligonucleotides
Cyclophilin
Forward 59-TAT CTG CAC TGC CAA GAC TGA GTG-39
Reverse 59-CTT CTT GCT GGT CTT GCC ATT CC-39
TNF-a
Forward 59-AAA TGG GCT CCC TCT CAT CAG TCC-39
Reverse 59-TCT GCT TGG TGG TTT GCT ACG AC-39
IL-6
Forward 59-TCC TAC CCC AAC TCC CAA TGC TC-39
Reverse 59-TTG GAT GGT CTT GGT CCY YAG CC-39
IL-1b
Forward 59-CAC CTC TCA AGC AGA GCA CAG-39
Reverse 59-GGG TTG CAT GGT GAA GTC AAC-39
IL-10
Forward 59-CAG ACC CAC ATG CTC CGA GA-39
Reverse 59-CAA GGC TTG GCA ACC CAA GTA-39
IFN-c
Forward 59-GAT CCA GCA CAA AGC TGT CA-39
Reverse 59-GAC TCC TTT TCC GCT TCC TT-39
MMP-1a
Forward 59-AGG AGC ACT AAT GTT CCC CAG CT-39
Reverse 59-TGG GAT TTG GGG AAG GCC CAT A-39
MMP-8
Forward 59-GGA GTG TGC CAT CAA CCC TGA CC-39
Reverse 59-TGT CAC CAT GGT CTC TTG AGA CGA-39
MMP-13
Forward 59-ACC CAG CCC TAT CCC TTG ATG CC-39
Reverse 59-GGT GCA GAC GCC AGA AGA ATC TGT-39
IFN: interferon; IL: interleukin; MMP: matrix metalloproteinase;
TNF: tumor necrosis factor.
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dehiscence. Evaluations based on immunohistochemistry
and zymography demonstrated increased levels of MMP-2,
MMP-3, MMP-8, andMMP-9 in colonic anastomoses of rats
(23), whereas MMP-10 and MMP-13 were not associated
with the healing of intestinal anastomoses (24).
In a previous study, we found that positive modulation of
MMP-1a and negative modulation of MMP-8 gene expres-
sion were associated with loss of anastomotic strength of
left colonic anastomoses in rats after CLP-induced abdom-
inal sepsis on the third POD. On the seventh POD,
anastomotic breaking strength in the same group was
higher than that in saline-treated animals, but MMP-1a and
MMP-8 gene expression remained unaltered (25). We can
assume that the MMP effect on anastomotic healing is not
dependent on the action of an isolated MMP, but is the
result of the interaction of different classes of endopepti-
dases. Moreover, the study of MMP activity by immunohis-
tochemical staining or mRNA analysis does not necessarily
mean that matrix degradation will occur, since strict control
of MMP activity is preserved when MMPs are released as
inactive proenzymes or by the presence of inhibitors (26).
Several authors have analyzed the variation in cytokine
levels postoperatively and the occurrence of complications
(27,28). Herwig et al. (28) reported a marked increase in IL-
6 and TNF-a levels, which may be regarded as a precursor
event that occurs days before the secondary clinical signs
of anastomotic leakage. The authors also reported that the
increase in IL-1b cytokine levels became statistically
significant on the third POD in patients with anastomotic
dehiscence (28). In addition, a positive correlation has
been described between IL-1b, IL-6, and TNF-a levels and
prolonged operative time, blood loss, and bacterial
contamination of peritoneal fluid (29).
In the present study, in the absence of sepsis,
administration of bromopride positively modulated IL-6,
IFN-c, and IL-10 gene expression on the third POD and
gene expression of all ILs on the seventh POD. In the group
of septic animals, administration of bromopride was
associated with increased IFN-c gene expression and
decreased TNF-a, IL-6, and IL-10 gene expression on the
third POD. On the seventh POD, gene expression of all
cytokines was positively modulated, except for TNF-a.
Therefore, we were not able to define a cytokine
profile (pro- or anti-inflammatory) that could be respon-
sible for the loss of strength of colonic anastomoses in the
rat on the third POD during bromopride administration,
since there is no consensus on which ILs are the most
important cytokines in each phase of the healing process.
It is worth mentioning, however, that detection of cytokine
gene expression or even cytokine levels in tissues or
secretions does not always correlate with its biological
activity. Instead of being produced, cytokines may have
been released as inactive proenzymes or may have
already been degraded (30).
In conclusion, bromopride interferes with MMP and IL
gene expression during anastomotic healing. Further
studies are needed to correlate these changes with the
healing process.
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